Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$8.99 - $16.86 $17,152 - $32,168
1,908 Added 18.82%
12,044 $195,000
Q3 2023

Nov 14, 2023

BUY
$10.81 - $22.96 $1,599 - $3,398
148 Added 1.48%
10,136 $139,000
Q2 2023

Aug 11, 2023

SELL
$17.19 - $24.34 $111,769 - $158,258
-6,502 Reduced 39.43%
9,988 $220,000
Q1 2023

May 16, 2023

BUY
$17.67 - $26.07 $291,378 - $429,894
16,490 New
16,490 $358,000
Q3 2022

Nov 14, 2022

SELL
$14.64 - $26.7 $597,502 - $1.09 Million
-40,813 Reduced 80.5%
9,886 $225,000
Q2 2022

Aug 15, 2022

SELL
$10.54 - $24.2 $529,403 - $1.22 Million
-50,228 Reduced 49.77%
50,699 $700,000
Q1 2022

May 16, 2022

BUY
$20.81 - $37.29 $474,946 - $851,069
22,823 Added 29.22%
100,927 $2.29 Million
Q4 2021

Feb 14, 2022

BUY
$32.99 - $58.55 $625,754 - $1.11 Million
18,968 Added 32.08%
78,104 $2.91 Million
Q3 2021

Nov 15, 2021

BUY
$42.03 - $60.5 $1.14 Million - $1.64 Million
27,035 Added 84.22%
59,136 $2.5 Million
Q2 2021

Aug 11, 2021

SELL
$29.51 - $44.62 $1.35 Million - $2.04 Million
-45,652 Reduced 58.71%
32,101 $1.43 Million
Q1 2021

May 17, 2021

BUY
$32.95 - $44.24 $1.52 Million - $2.04 Million
46,108 Added 145.7%
77,753 $2.8 Million
Q4 2020

Feb 16, 2021

BUY
$27.5 - $45.75 $306,157 - $509,334
11,133 Added 54.28%
31,645 $1.26 Million
Q1 2020

May 15, 2020

BUY
$8.36 - $17.03 $171,480 - $349,319
20,512 New
20,512 $195,000
Q2 2019

Aug 14, 2019

SELL
$15.2 - $19.42 $1.34 Million - $1.71 Million
-88,099 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$10.9 - $21.26 $207,797 - $405,300
19,064 Added 27.61%
88,099 $1.58 Million
Q4 2018

Feb 14, 2019

BUY
$9.5 - $17.17 $655,832 - $1.19 Million
69,035 New
69,035 $830,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.13B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.